Open Accessibility Menu

Scleroderma Clinic

A Nationally Recognized Treatment Center

Scleroderma is an autoimmune disease which causes inflammation, fibrosis and narrowing of blood vessels in the skin, kidneys, lungs and other organs. Scleroderma is a rare disease affecting around 100,000 Americans. It is more common in women and certain ethnic groups.

The Division of Rheumatology at The GW Medical Faculty Associates is proud to host a nationally recognized scleroderma clinic dedicated to the treatment and management of patients with scleroderma. Directed by Dr. Victoria Shanmugam, the Scleroderma Clinic is home to the internationally recognized STOP Scleroderma study.

Our multidisciplinary team provides holistic care for patients with scleroderma, by focusing on controlling inflammation, and working with a team of specialists to slow progression and control symptoms of scleroderma.

Please contact the clinic at (202) 741-2488 to schedule an appointment in the Scleroderma Clinic. Appointments for this clinic are available on Fridays only.

Clinical Trials

  • Wound Etiology and Healing Study (WE-HEAL)
    The purpose of the WE-HEAL Study is to help researchers use human tissue samples and health records to study the reasons why some patients heal quickly and some have problems healing wounds. All patients seen with an open wound and Hidradenitis suppurativa are asked to participate. Information from this research may help to understand how to prevent and treat certain diseases.
  • STOP Scleroderma
    The Scleroderma bioreposiTOry and Pathogenesis Study (STOP Scleroderma) will help researchers use clinical data and human biospecimens to investigate why scleroderma patients develop certain complications from their disease. Patients with confirmed scleroderma, raynauds or positive autoantibodies are invited to participate. This research may help us understand how to prevent and treat scleroderma and other diseases.